Ilinca Nicolae

Learn More
The aim was to analyze humoral immune response against GM1 ganglioside expressed on the surface of melanocytic cells, and the possible correlation between the level of antibodies against GM1 IgG and IgM class and melanoma progression. The study included 128 adult patients with malignant melanoma, without paraneoplastic neurologic disorders, 48 adults with(More)
A1 The outcome of patients with recurrent versus non-recurrent pneumococcal meningitis in a tertiary health-care hospital in Background Pneumococcal meningitis (PM) is a life-threatening disease. Recurrent PM is relatively rare and associated with predisposing conditions. This study analyzed the outcome of patients with recurrent versus non-recurrent PM.(More)
BACKGROUND There are several circulatory biomarkers that are involved in forecasting the clinical outcome of cutaneous melanoma. Serum/plasma vitamin D status is one of the markers intensively studied in this type of cutaneous cancer. The combination of validated serum biomarkers (like LDH) with new biomarkers such as IL-8, angiogenic factor, and vitamin D(More)
Antigangliosides antibodies were observed in neoplastic diseases, bacterial and viral infections, autoimmune diseases and neurological disorders. Objective: assessment of antigangliosides antibodies anti-GM1,-GM2,-GM3,-GD1a,-GD1b,-GT1b,-GQ1b of IgG type in asympto-matic HIV patients. The study was based on the prospective analysis of 32 patients with(More)